RECONCILE TABLET (CHEWABLE)

Maa: Kanada

Kieli: englanti

Lähde: Health Canada

Osta se nyt

Pakkausseloste Pakkausseloste (PIL)
24-07-2018

Aktiivinen ainesosa:

FLUOXETINE (FLUOXETINE HYDROCHLORIDE)

Saatavilla:

PEGASUS LABORATORIES INC

Annos:

8MG

Lääkemuoto:

TABLET (CHEWABLE)

Koostumus:

FLUOXETINE (FLUOXETINE HYDROCHLORIDE) 8MG

Antoreitti:

ORAL

Kpl paketissa:

30

Prescription tyyppi:

Prescription

Terapeuttinen ryhmä:

DOGS

Tuoteyhteenveto:

Active ingredient group (AIG) number: 0116847005

Valtuutuksen tilan:

APPROVED

Valtuutus päivämäärä:

2018-07-24

Pakkausseloste

                                PRODUCT LABEL PROFILE
_Version 2 _
_–_
_ July 12, _
_2018_
BOTTLE LABEL ENGLISH - 8 mg
Dosage and Administration:
For use in dogs only. The
recommended dose of Reconcile
chewable tablets is 1-2 mg/kg
administered once daily, in conjunction
with a behaviour modification plan.
Storage:
Store at 20-25°C; excursions permitted
between 15-30°C. Do not remove
desiccant canister from the bottle.
Completely close bottle between uses.
Pegasus Laboratories, Inc.
8809 Ely Road
Pensacola, FL USA 32514
CA4203
DIN 02307952
PR
RECONCILE®
fluoxetine (as fluoxetine hydrochloride) chewable tablets
For Veterinary Use Only
A selective serotonin reuptake inhibitor (SSRI)
for the treatment of canine
SEPARATION ANXIETY
in conjunction with a behaviour modification plan
8
mg
4.0-8.0 kg
Net: 30 Tablets
For complete product information,
see package insert.
Imported and distributed by:
_To be determined_
_ _
®
Pegasus Laboratories, Inc.
Warnings: Not for use in humans.
Keep out of reach of children.
Logo
LOT
EXP
PRODUCT LABEL PROFILE
_Version 2 _
_–_
_ July 12, _
_2018_
BOTTLE LABEL FRENCH - 8 mg
CA4203
PR
RECONCILE®
DIN 02307952
Veuillez consulter la notice
d
’
accompagnement pour obtenir
des renseignements complets sur
le produit.
fluoxétine (sous forme de chlorhydrate de fluoxétine)
comprimés à
croquer
Pour usage veterinaire seulement
Un inhibiteur sélectif du recaptage de la sérotonine
(ISRS)
pour le traitement de
l'ANXIÉTÉ DE SÉPARATION
chez le chien en concomitance avec un
programme de modification du
comportement
8 mg
4,0 à 8,0 kg
Net : 30 comprimes
Logo
LOT
EXP
PRODUCT LABEL PROFILE
_Version 2 – July 12, 2018_
FRONT PANEL ENGLISH - CARTON 8 mg
CA4203
DIN 02307952
Dog Logo
PR
RECONCILE
®
FLUOXETINE (AS FLUOXETINE HYDROCHLORIDE) CHEWABLE TABLETS
For Veterinary Use Only
A selective serotonin reuptake inhibitor (SSRI) for
the treatment of canine SEPARATION
ANXIETY
in conjunction with a behaviour modification plan
8 mg
4.0-8.0 kg
Net: 30 Tablets, 8 mg each
Logo
WARNINGS: NOT FOR USE IN HUMANS. KEEP
OUT OF REACH OF 
                                
                                Lue koko asiakirja
                                
                            

Asiakirjat muilla kielillä

Pakkausseloste Pakkausseloste ranska 24-07-2018

Etsi tähän tuotteeseen liittyviä ilmoituksia